» Articles » PMID: 16983549

Outcome in Bacteremia Associated with Nosocomial Pneumonia and the Impact of Pathogen Prediction by Tracheal Surveillance Cultures

Overview
Specialty Critical Care
Date 2006 Sep 20
PMID 16983549
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess whether pathogen prediction in bacteremia associated with nosocomial pneumonia (NP) by tracheal surveillance cultures improves adequacy of early antibiotic therapy and impacts mortality.

Design And Setting: A retrospective observational study of a prospectively gathered cohort. This cohort included all adult patients admitted to the ICU of a tertiary care hospital from 1992 through 2001 and who developed bacteremia associated with NP.

Measurements And Main Results: 128 episodes of bacteremia associated with NP were identified. In 110 episodes a tracheal surveillance culture 48-96h prior to bacteremia was available: this culture predicted the pathogen in 67 episodes (61%). Overall rates of appropriate empiric antibiotic therapy within 24 and 48h were 62 and 87%, respectively. Pathogen prediction was associated with a significantly higher rate of appropriate antibiotic therapy within 24h (71 vs 45%; p=0.01), but not within 48h (91 vs 82%; p=0.15). Crude in-hospital mortality was 50%. Pathogen prediction was associated with increased survival in univariate (OR 0.43; CI 0.19-0.93; p=0.04) and multivariate analysis (OR 0.32; CI 0.12-0.82; p=0.02). Multivariate analysis further identified age (OR 1.04; CI 1.01-1.07; p=0.02), increasing APACHEII score (OR 1.08; CI 1.02-1.15; p=0.01), and methicillin-resistant Staphylococcus aureus (OR 5.90; CI 1.36-25.36; p=0.01) and Pseudomonas aeruginosa (OR 3.30; CI 1.04-10.4; p=0.04) as independent risk factors for mortality.

Conclusion: Pathogen prediction in bacteremia associated with NP by tracheal surveillance cultures is associated with a higher rate of adequate empiric antibiotic therapy within 24[Symbol: see text]h and with increased survival.

Citing Articles

Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.

Blot S, Ruppe E, Harbarth S, Asehnoune K, Poulakou G, Luyt C Intensive Crit Care Nurs. 2022; 70:103227.

PMID: 35249794 PMC: 8892223. DOI: 10.1016/j.iccn.2022.103227.


Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.

Teysseyre L, Ferdynus C, Miltgen G, Lair T, Aujoulat T, Lugagne N Antimicrob Resist Infect Control. 2019; 8:78.

PMID: 31139361 PMC: 6528287. DOI: 10.1186/s13756-019-0529-z.


Epidemiology of Multidrug Resistant Infections after Inter-ICU Transfer in India.

Choudhuri A, Ahuja B, Biswas P, Uppal R Indian J Crit Care Med. 2019; 23(1):1-6.

PMID: 31065200 PMC: 6481264. DOI: 10.5005/jp-journals-10071-23103.


Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.

Joo E, Park D, Kang C, Chung D, Song J, Lee S Korean J Intern Med. 2018; 34(6):1347-1362.

PMID: 29347812 PMC: 6823568. DOI: 10.3904/kjim.2017.098.


Clinical manifestations of pneumonia according to the causative organism in patients in the intensive care unit.

Lee J, Lee J, Park Y, Lee C, Yim J, Yoo C Korean J Intern Med. 2015; 30(6):829-36.

PMID: 26552458 PMC: 4642012. DOI: 10.3904/kjim.2015.30.6.829.


References
1.
Colardyn F . Appropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems. Acta Clin Belg. 2005; 60(2):51-62. DOI: 10.1179/acb.2005.011. View

2.
Iregui M, Ward S, Sherman G, Fraser V, Kollef M . Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002; 122(1):262-8. DOI: 10.1378/chest.122.1.262. View

3.
Kollef M, Sherman G, Ward S, Fraser V . Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999; 115(2):462-74. DOI: 10.1378/chest.115.2.462. View

4.
Wunderink R, Rello J, Cammarata S, Croos-Dabrera R, Kollef M . Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003; 124(5):1789-97. View

5.
Vincent J . Nosocomial infections in adult intensive-care units. Lancet. 2003; 361(9374):2068-77. DOI: 10.1016/S0140-6736(03)13644-6. View